Why the study?
Does the availability of highly sensitive troponin assays reduce inhospital major adverse cardiac events in patients presenting with possible acute coronary syndrome?
Population
4,371 consecutive patients presenting to 283 hospitals in Australia and New Zealand with possible acute…
Comparison
Availability and use of highly sensitive… vs Availability and use of sensitive troponin assay
Design
Cohort
Follow-up
inhospital
Authors
Loading...
May support hs-troponin use to lower inhospital events in possible ACS; leaves open need for randomized confirmation.
Does the availability of highly sensitive troponin assays reduce inhospital major adverse cardiac events in patients presenting with possible acute coronary syndrome?
The use of highly sensitive troponin assays in patients with possible ACS is associated with increased utilization of non-invasive cardiac investigations and a reduction in inhospital adverse events.
Cullen et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: